This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Troy Lionberger, PhD
Chief Business Officer at A-Alpha Bio
Speaker

Profile

Troy leads Business Development and Alliance Management at A-Alpha Bio. He began his career at the bench after earning his PhD from the University of Michigan and completing a postdoctoral fellowship at UC Berkeley. Over nine years at Berkeley Lights, Troy held leadership roles across R&D, product strategy, and business development—ultimately driving commercial efforts that secured over $200M in deals spanning biopharma, agriculture, and industrial biotechnology. Prior to joining A-Alpha, he served as Chief Business Officer at Abbratech, where he led the company’s transition from a stealth-mode antibody discovery platform to a partner-facing biotech. Troy brings deep technical fluency and a proven ability to scale platform businesses through transformative partnerships.

Agenda Sessions

  • How Millions of Affinity Measurements Enable Predictive Multi-parameter Antibody Optimization in Weeks

    07:40